Jazz Pharma director sells 1,855 shares for taxes

A Jazz Pharmaceuticals director used 1,855 shares to satisfy tax obligations from RSU vesting, not as an open-market sale.

Rhea-AI Filing Summary

Jazz Pharmaceuticals plc (JAZZ) director Heather Ann McSharry reported two dispositions of Ordinary Shares on August 31, 2026 to cover tax obligations from the vesting of previously granted restricted stock units. A total of 1,855 shares were delivered or withheld for tax payment, and no Rule 10b5-1 plan is reported.

Insider Trade Summary

Tax Withholding: 1,855 shares

Tax Withholding 2 txns

Insider McSharry Heather Ann

Role Director

Type	Security	Shares	Price	Value
Tax Withholding	Ordinary Shares F1	15	$244.6447	$4K
Tax Withholding	Ordinary Shares F1	1,840	$241.39	$444K

Holdings After Transaction: Ordinary Shares — 18,199 shares (Direct)

Footnotes (1)

1. F1. Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Key Figures

Shares disposed for tax payment (small lot): 15 shares Shares disposed for tax payment (primary lot): 1,840 shares Total shares delivered or withheld for tax: 1,855 shares +1 more

4 metrics

Shares disposed for tax payment (small lot) 15 shares Code F disposition on August 31, 2026 at $244.6447 per share

Shares disposed for tax payment (primary lot) 1,840 shares Code F disposition on August 31, 2026 at $241.39 per share

Total shares delivered or withheld for tax 1,855 shares Sum of both Code F tax-withholding dispositions reported

Transaction code F Both transactions coded as payment of tax liability by delivering or withholding securities

Key Terms

restricted stock units, tax obligations, beneficial ownership

3 terms

restricted stock units financial

"arising out of the vesting of previously granted restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax obligations financial

"Shares sold to satisfy tax obligations arising out of the vesting"

beneficial ownership financial

"relates to her beneficial ownership and tax-withholding share dispositions"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

What insider transactions did JAZZ director Heather Ann McSharry report on August 31, 2026?

She reported two dispositions of Ordinary Shares on August 31, 2026, totaling 1,855 shares, used to satisfy tax obligations arising from the vesting of previously granted restricted stock units.

Were the August 31, 2026 JAZZ Form 4 transactions open-market sales?

No. The filing states the shares were sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units, which indicates tax-withholding transactions rather than discretionary open-market sales.

How many JAZZ shares were used to cover taxes in each Form 4 transaction?

One transaction involved 15 Ordinary Shares at a reported price of $244.6447 per share, and a second involved 1,840 Ordinary Shares at a reported price of $241.39 per share, both used to satisfy tax obligations.

Did the JAZZ Form 4 indicate use of a Rule 10b5-1 trading plan?

No. The document-level Rule 10b5-1 checkbox is not checked, so the filing does not report that these transactions were made pursuant to a Rule 10b5-1 trading plan.

What role does Heather Ann McSharry have at Jazz Pharmaceuticals (JAZZ)?

Heather Ann McSharry is reported as a director of Jazz Pharmaceuticals plc. The Form 4 relates to her beneficial ownership and tax-withholding share dispositions connected to restricted stock unit vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 05:14 PM Accepted by SEC EDGAR 09/02/2026 - 05:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McSharry Heather Ann

(Last) (First) (Middle)

5TH FL, WATERLOO EXCHANGE

WATERLOO RD

(Street)

DUBLIN 4

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Jazz Pharmaceuticals plc [ JAZZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/31/2026		F(1)		15	D	$244.6447	20,039	D
Ordinary Shares	08/31/2026		F(1)		1,840	D	$241.39	18,199	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

	By: /s/Paz Dizon, as attorney in fact For: Heather Ann McSharry	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)